Approval · Notice of Compliance 4450 · 1996
VAQTA: Notice of Compliance 4450
Issued September 30, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4450
- Date
- September 30, 1996
- Company
- Merck Manufacturing Division, Division Of Merck & Co., Inc.West Point, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VAQTA | 02229702 | Marketed |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 50 UNIT per ML